Efficacy and Safety of Qiaoshao Formula(翘芍方) on Patients with Lifelong Premature Ejaculation of Gan(Liver) Depression and Shen(Kidney) Deficiency Syndrome:A Randomized Controlled Trial

Objective: To observe the efficacy and safety of Qiaoshao Formula(翘芍方, QSF) on patients with lifelong premature ejaculation(LPE) of Gan(Liver) depression and Shen(Kidney) deficiency syndrome. Methods: A total of 60 LPE patients were randomly divided into treatment(QSF) and control(dapoxetine) groups...

Full description

Saved in:
Bibliographic Details
Published in中国结合医学杂志:英文版 Vol. 22; no. 12; pp. 889 - 893
Main Author 郭军 高庆和 王福 余国今 张继伟 曾银 耿强 郭博达 韩强
Format Journal Article
LanguageEnglish
Published 2016
Online AccessGet full text
ISSN1672-0415
1993-0402

Cover

More Information
Summary:Objective: To observe the efficacy and safety of Qiaoshao Formula(翘芍方, QSF) on patients with lifelong premature ejaculation(LPE) of Gan(Liver) depression and Shen(Kidney) deficiency syndrome. Methods: A total of 60 LPE patients were randomly divided into treatment(QSF) and control(dapoxetine) groups. The treatment group received QSF twice a day and the control group received dapoxetine 1 to 2 h prior to planned sexual intercourse for 4 weeks. The outcomes included intra-vaginal ejaculation latency time(IELT), premature ejaculation diagnostic tool(PEDT), clinical global impression of change(CGIC), scores of Chinese medicine symptoms(CMSS), sex life satisfaction(SLS) and adverse events(AEs). Results: In the treatment group, the median IELT was 3 min vs. 1.5 min before and after treatment(P〈0.05). PEDT in the treatment group was reduced to 11.76±1.68 from 15.83±2.30 after treatment(P〈0.05). Besides, patient's SLS was improved from 1.30±0.05 to 6.30±0.04(P〈0.05), and spouse's SLS was increased from 1.30±0.08 to 6.10±0.06(P〈0.05); CMSS was decrease from 14.86±3.02 to 9.62±2.87(P〈0.05). In addition, no significant AE was observed in both groups. Conclusion: QSF may be effective and safe on LPE patients with Gan depression and Shen deficiency syndrome.
Bibliography:lifelong premature ejaculation Qiaoshao Formula Chinese medicine dapoxetine intra-vaginal ejaculation latency time premature ejaculation diagnostic tool
11-4928/R
Objective: To observe the efficacy and safety of Qiaoshao Formula(翘芍方, QSF) on patients with lifelong premature ejaculation(LPE) of Gan(Liver) depression and Shen(Kidney) deficiency syndrome. Methods: A total of 60 LPE patients were randomly divided into treatment(QSF) and control(dapoxetine) groups. The treatment group received QSF twice a day and the control group received dapoxetine 1 to 2 h prior to planned sexual intercourse for 4 weeks. The outcomes included intra-vaginal ejaculation latency time(IELT), premature ejaculation diagnostic tool(PEDT), clinical global impression of change(CGIC), scores of Chinese medicine symptoms(CMSS), sex life satisfaction(SLS) and adverse events(AEs). Results: In the treatment group, the median IELT was 3 min vs. 1.5 min before and after treatment(P〈0.05). PEDT in the treatment group was reduced to 11.76±1.68 from 15.83±2.30 after treatment(P〈0.05). Besides, patient's SLS was improved from 1.30±0.05 to 6.30±0.04(P〈0.05), and spouse's SLS was increased from 1.30±0.08 to 6.10±0.06(P〈0.05); CMSS was decrease from 14.86±3.02 to 9.62±2.87(P〈0.05). In addition, no significant AE was observed in both groups. Conclusion: QSF may be effective and safe on LPE patients with Gan depression and Shen deficiency syndrome.
ISSN:1672-0415
1993-0402